Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
Recruiting · NCT07179809 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Demographics/Lifestyle Survey
What this trial is about
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with HR+/HER2 negative MBC
- On first- or second-line treatment
- Life expectancy at least 12 months
- Only females
- Age 18 years or older
- Able to read, write, and speak English
- Willingness to follow protocol requirements
- Have a smartphone with access to cellular service or computer access with internet service
- Oriented to person, place, and time
- Consume less than 3 servings of fruit and vegetable/day
- Engage in less than 150 minutes moderate/vigorous intensity activity per week, defined as anything that causes small increases in breathing or heart rate for a sustained amount of time (e.g., brisk walking, bicycling)
- Engage in a mind-body practice less than 4 times a month
Exclusion criteria
- Another primary cancer diagnosis within past 5 years (not including non-melanoma skin cancers)
- Any major thought disorder (e.g., schizophrenia, dementia)
- Communication barriers (e.g., hard of hearing)
- Poorly-controlled or uncontrolled diabetes in the opinion of the physician(s)
- Extreme mobility issues (e.g., unable to get in and out of a chair unassisted)
Where it is running
1 location listed across 1 US state.
- The University of Texas M. D. Anderson Cancer Center - Houston, Texas, United States